REFRACTORY ACUTE LEUKEMIA
Clinical trials for REFRACTORY ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cocktail aims to beat back tough leukemia
Disease control OngoingThis phase 2 trial tests a combination of chidamide, azacytidine, and a chemotherapy regimen (HAG) in 21 adults with acute myeloid leukemia that has come back or not responded to treatment. The goal is to see how well the combo works and what side effects it causes. Participants …
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug shows promise for rare childhood cancers
Disease control OngoingThis study tests a drug called larotrectinib in children and young adults (up to age 30) with certain cancers that have a specific genetic change called a TRK fusion. The goal is to see if the drug can shrink solid tumors or control leukemia that has returned. The drug works by b…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC